Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Cowealth Medical Holding Co's EV-to-EBIT or its related term are showing as below:
ROCO:4745'
s EV-to-EBIT Range Over the Past 10 Years
Min: -283.34 Med: 9.92 Max: 158.41
Current: -13.52
During the past 13 years, the highest EV-to-EBIT of Cowealth Medical Holding Co was 158.41. The lowest was -283.34. And the median was 9.92.
ROCO:4745's EV-to-EBIT is ranked worse than 100% of 474
companies
in the Medical Devices & Instruments industry
Industry Median: 18.7
vs ROCO:4745: -13.52
Cowealth Medical Holding Co (ROCO:4745) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Cowealth Medical Holding Co's Enterprise Value for the quarter that ended in Jun. 2026 was NT$3,890 Mil.
Cowealth Medical Holding Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-276 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cowealth Medical Holding Co EV-to-EBIT Related Terms
Cowealth Medical Holding Co EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Cowealth Medical Holding Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cowealth Medical Holding Co EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cowealth Medical Holding Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Cowealth Medical Holding Co's EV-to-EBIT falls into.
Cowealth Medical Holding Co's current Enterprise Value is NT$3,728 Mil.
Cowealth Medical Holding Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-276 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cowealth Medical Holding Co (ROCO:4745) has a EV-to-EBIT of -13.52 as of Sep. 02, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Cowealth Medical Holding Co and its competitors. According to the industry distribution chart, Cowealth Medical Holding Co ranks #999999 out of 474 companies in the Medical Devices & Instruments industry.
Is Cowealth Medical Holding Co's EV-to-EBIT too high?
Cowealth Medical Holding Co's current EV-to-EBIT is -13.52. Based on the distribution chart, Cowealth Medical Holding Co ranks #999999 out of 474 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Cowealth Medical Holding Co has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cowealth Medical Holding Co's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cowealth Medical Holding Co ranks #999999 out of 474 companies for EV-to-EBIT. This places Cowealth Medical Holding Co in the lower half of its industry. The industry median EV-to-EBIT is 18.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.70, based on 474 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Cowealth Medical Holding Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cowealth Medical Holding Co's current EV-to-EBIT is -13.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cowealth Medical Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Cowealth Medical Holding Co (ROCO:4745) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$14.18, compared to a current price of NT$11.80 — trading 16.8% below its estimated fair value. The current EV-to-EBIT is -13.52. Cowealth Medical Holding Co's overall GF Score™ is 53/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Cowealth Medical Holding Co (ROCO:4745), the current EV-to-EBIT is -13.52 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cowealth Medical Holding Co (ROCO:4745) Overvalued in 2026?
Based on GuruFocus' analysis, Cowealth Medical Holding Co stock appears to be undervalued.
The current stock price of NT$11.80 is trading 16.8% below its estimated GF Value™ of NT$14.18.
GuruFocus considers Cowealth Medical Holding Co to be Modestly Undervalued.
Key valuation signals for ROCO:4745:
EV-to-EBIT: -13.52
GF Value™: NT$14.18 vs. price of NT$11.80 (16.8% below fair value)
No single metric tells the full story. See the ROCO:4745 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cowealth Medical Holding Co Ltd is mainly involved in trading medical equipment, reagents, and spare parts. Its wide range of solutions includes refined management services tailored for in-vitro diagnostic products, reagents, and consumables, an integrated platform designed for decision-making and analysis, commercialization of achievements in medical science and technology, a Multi-Channel Coaxial Time Audio Video Imaging Platform (MCCTAVIP), and an AI-assisted system for clinical diagnosis. The Group has two reportable segments: Segment A, which generates maximum revenue and sells equipment, and Segment B, which sells reagents and others. Geographically, it generates maximum revenue from China and Hong Kong, and the rest from Taiwan.
53GF Score
Get the complete analysis for ROCO:4745
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4745 has been successfully added to your 
